Abacus Property Stapled Securities RPE
Was ist das RPE von Abacus Property Stapled Securities?
RPE von Abacus Property Group Stapled Securities ist AUD$3.497M
Was ist die Definition von RPE?
Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.
RPE von Unternehmen in Real Estate Sektor auf ASX im Vergleich zu Abacus Property Stapled Securities
Was macht Abacus Property Stapled Securities?
Abacus Property Group (ASX:ABP), is a diversified Australian REIT with an investment portfolio concentrated in the Office and Self Storage sectors. We invest capital in real estate opportunities to deliver superior long term returns and maximise securityholder value. Abacus is a strong asset backed, annuity style business model where capital is directed towards assets that provide potential for enhanced income growth and ultimately create value. Our people, market insight and repositioning capability together with strategic partnering are the key enablers of our strategy. Located in a single corporate office in Sydney, Australia, Abacus is listed on the Australian Stock Exchange and is included in the S&P/ASX 200 index. Abacus is comprised of Abacus Group Holdings Limited (the nominated parent entity), Abacus Group Projects Limited and Abacus Storage Operations Limited, Abacus Trust, Abacus Income Trust and Abacus Storage Property Trust. The shares and units in these entities are stapled together and trade as one security in ABP.
Unternehmen mit rpe ähnlich Abacus Property Stapled Securities
- Parex Resources hat RPE von $3.489M
- Ultra Petroleum hat RPE von $3.490M
- Indian Overseas Bank hat RPE von ₨3.492M
- Angang Steel hat RPE von ¥3.495M
- Kamat Hotels (India) hat RPE von ₨3.496M
- Ping An Insurance () Co. of China hat RPE von ¥3.497M
- Abacus Property Stapled Securities hat RPE von AUD$3.497M
- iQIYI hat RPE von ¥3.497M
- BEML hat RPE von ₨3.500M
- CSL Finance hat RPE von ₨3.501M
- TUS International hat RPE von HKD$3.501M
- Daphne International hat RPE von HKD$3.502M
- Sun Pharma Advanced Research hat RPE von ₨3.505M